Global Interventional Oncology Market Size & Trends Report Segmented by Technique (Ablation Therapies, Embolization Therapies), Procedure (Tumor Ablation, Tumor Biopsy), Application (Liver Cancer, Lung Cancer), End-user & Regional Forecasts to 2030

The interventional oncology market is projected to grow at a CAGR of 11% over the forecast period. Major factors driving growth include the increasing prevalence of cancer globally, the rising adoption of minimally invasive procedures, advancements in imaging technologies, and an aging population susceptible to oncology-related diseases. Additionally, growing awareness of interventional oncology among healthcare providers further accelerates its adoption. However, the market faces restraints such as high procedural costs, limited skilled professionals, and stringent regulatory approvals for innovative technologies. To learn more about this report, download the PDF brochure.

Report Overview

Interventional oncology is a rapidly evolving subspecialty of interventional radiology that focuses on diagnosing and treating cancer using minimally invasive procedures. It employs advanced imaging techniques such as ultrasound, CT scans, and MRI to guide targeted therapies directly to tumors. Procedures include thermal ablation (radiofrequency and microwave ablation), transarterial chemoembolization (TACE), and selective internal radiation therapy (SIRT). These techniques provide precise treatment while minimizing damage to healthy tissues, resulting in reduced recovery time and fewer complications compared to traditional cancer treatments.

To learn more about this report, download the PDF brochure.

Rising Cancer Incidence and Shifting Focus Toward Patient-Centric Care

The growing incidence of cancer worldwide is a significant factor driving the interventional oncology market. According to the International Agency for Research on Cancer (IARC), there were close to 20 million new cases of cancer in 2022, alongside 9.7 million deaths from cancer. With millions of new cancer cases diagnosed annually, there is an urgent demand for advanced treatment options that provide effective outcomes while minimizing patient burden. Interventional oncology fulfils this need by offering image-guided, minimally invasive procedures such as thermal ablation and embolization therapies. These approaches reduce surgical trauma, shorten hospital stays, and improve post-treatment quality of life, especially for patients who are elderly or have underlying health conditions. Moreover, healthcare systems are increasingly prioritizing patient-centric care by adopting innovative methods that balance clinical efficacy with cost efficiency. As awareness of these benefits grows among oncologists and patients, the adoption of interventional oncology continues to expand globally.

To learn more about this report, download the PDF brochure.

AI-Driven Precision in Interventional Oncology

The integration of artificial intelligence (AI) into interventional oncology represents a transformative advancement in the field. AI enhances procedural accuracy by improving tumour visualization, segmentation, and monitoring in imaging modalities like CT, MRI, and ultrasound. This allows clinicians to precisely plan and execute minimally invasive treatments, optimizing outcomes for patients. AI-powered tools also assist in predicting treatment responses and customizing therapies based on patient-specific factors, enabling a personalized approach to cancer care. Additionally, automated analysis of imaging data reduces the time required for diagnosis and decision-making, streamlining workflows and improving efficiency for healthcare providers. As these AI applications become more sophisticated, they contribute to higher success rates, fewer complications, and greater accessibility to advanced interventional oncology techniques, positioning AI as a cornerstone of future innovation in cancer treatment.

Competitive Landscape Analysis

The global interventional oncology market is marked by the presence of established and emerging market players such as Medtronic plc; Boston Scientific Corporation; Johnson & Johnson; Cook Medical; Becton, Dickinson and Company; AngioDynamics Inc.; Stryker Corporation; B. Braun Melsungen AG; Terumo Corporation; Siemens Healthineers; and GE Healthcare among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

Report Scope

Report Scope	Details
Base Year Considered	2024
Historical Data	2023 - 2024
Forecast Period	2025 - 2030
Growth	11%
Market Drivers	Increasing prevalence of cancer worldwide Rising preference for minimally invasive procedures Advancements in imaging technologies (e.g., CT, MRI, and ultrasound) Growing geriatric population susceptible to oncology-related diseases Rising awareness and acceptance of interventional oncology among healthcare professionals
Attractive Opportunities	Growing adoption of ablation techniques such as microwave and radiofrequency ablation Emerging markets offering the untapped potential for interventional oncology procedures Increased investment in research and development of innovative therapies Expanding applications of interventional oncology in combination therapies for better clinical outcomes
Segment Scope	Technique, Procedure, Application, and End-user
Regional Scope	North America (US & Canada) Europe (UK, Germany, France, Italy, Spain, Rest of Europe) Asia Pacific (China, India, Japan, Rest of Asia Pacific) Latin America Middle East & Africa
Key Companies Mapped	Medtronic plc; Boston Scientific Corporation; Johnson & Johnson; Cook Medical; Becton, Dickinson and Company; AngioDynamics Inc.; Stryker Corporation; B. Braun Melsungen AG; Terumo Corporation; Siemens Healthineers; and GE Healthcare among others
Report Highlights	Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis

Market Segmentation

This report by Medi-Tech Insights provides thesize of the global interventional oncology market at theregional- and country-level from 2023 to 2030. The report further segments the market based on technique, procedure, application and end-user.

• Market Size & Forecast (2023-2030), By Technique, USD Million
  • Ablation Therapies
    • Radiofrequency Ablation (RFA)
    • Microwave Ablation (MWA)
    • Cryoablation
    • Laser Ablation
    • Irreversible Electroporation (IRE)
  • Embolization Therapies
    • Transarterial Chemoembolization (TACE)
    • Transarterial Radioembolization (TARE)
  • Biopsy Techniques
    • Core Needle Biopsy
    • Fine Needle Aspiration (FNA)
  • Targeted Therapy Delivery Systems
    • Drug-eluting Beads
    • Radioembolization
    • Drug-eluting Stents
    • Injectable Hydrogels and Nanoparticles
    • Othd Therapy Systems
  • Image-Guided Procedures
    • Ultrasound Guidance
    • CT Scan Guidance
    • MRI Guidance
    • Fluoroscopy Guidance
• Market Size & Forecast (2023-2030), By Procedure, USD Million
  • Tumor Ablation
  • Tumor Biopsy
  • Vascular Interventions
  • Palliative Care

• Market Size & Forecast (2023-2030), By Application, USD Million
  • Liver Cancer
  • Lung Cancer
  • Kidney Cancer
  • Prostate Cancer
  • Breast Cancer
  • Other Cancer

• Market Size & Forecast (2023-2030), By End-user, USD Million
  • Hospitals
  • Specialty Centers
  • Others
• Market Size & Forecast (2023-2030), By Region, USD Million
  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa